Ebenbuild has announced that it received a €2.3 million grant from the European Innovation Council Accelerator program to advance its digital twin platform technology. The funding supports the market launch of Twinhale, the first in silico trial software for pulmonary drug delivery. Additionally, the EIC fund will invest up to €10 million in future equity financing rounds raised by Ebenbuild. This investment will aid in transforming respiratory care through personalized lung simulation.
Who to call at Ebenbuild, and when
A new round usually means Ebenbuild is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Ebenbuild raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Ebenbuild, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ebenbuild. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Ebenbuild
Location
Munich, Bavaria, Germany
About
Ebenbuild is a digital health tech pioneer developing precise, patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. Its digital toolset is based on physics-based simulation, AI, and data science and is designed to support decision makers in the life sciences industry, clinicians, and physicians. Ebenbuild's approach provides a better understanding of respiratory diseases and individual pathophysiology enabling a new class of products and services ranging from in silico trials to accelerate and de-risk the development of inhaled drugs to personalized treatment options that improve the chances of survival and recovery in millions of cases of respiratory conditions such as Acute Respiratory Distress Syndrome (ARDS) each year.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ebenbuild raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MunichInformation TechnologyBiotechnologyHealth CareMedical